Predicting the future development of mild cognitive impairment in the cognitively healthy elderly
Strange, B.; Zhang, L.; Sierra-Marcos, A.; Alfayate, E.; Tohka, J.; Medina, M.
Show abstract
Identifying measures that predict future cognitive impairment in healthy individuals is necessary to inform treatment strategies for candidate dementia-preventative and modifying interventions. Here, we derive such measures by studying "converters" who transitioned from cognitively normal at baseline to mild-cognitive impairment (MCI) in a longitudinal study of 1213 elderly participants. We first establish reduced grey matter density (GMD) in left entorhinal cortex (EC) as a biomarker for impending cognitive decline in healthy individuals, employing a matched sampling control for several dementia risk-factors, thereby mitigating the potential effects of bias on our statistical tests. Next, we determine the predictive performance of baseline demographic, genetic, neuropsychological and MRI measures by entering these variables into an elastic net-regularized classifier. Our trained statistical model classified converters and controls with validation Area-Under-the-Curve>0.9, identifying only delayed verbal memory and left EC GMD as relevant predictors for classification. This performance was maintained on test classification of out-of-sample converters and controls. Our results suggest a parsimonious but powerful predictive model for MCI development in the cognitively healthy elderly.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cognitive Reserve Against Alzheimer's Pathology Is Linked to Brain Activity During Memory Formation 97%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 96%
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 96%
Similar papers in this journal
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 97%
- Glucose metabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease 97%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 96%